2,2-bis(4-hydroxy-3-tert-butylphenyl)propane

Star0

DB13008InvestigationalSmall molecule

TBD has been used in trials studying the treatment of Adenocarcinoma.

Formula / weight: C₂₃H₃₂O₂ · 340.507 g/mol (avg)

Resolves to

Compound

UNIIOKF3E6VGQBCAS79-96-9PubChem66237

Clinical / RWD

RxNorm2267021

Structure

InChIKeyZDRSNHRWLQQICP-UHFFFAOYSA-NSMILESCC(C)(C)C1=CC(=CC=C1O)C(C)(C)C1=CC=C(O)C(=C1)C(C)(C)C

Which companies are running trials of 2,2-bis(4-hydroxy-3-tert-butylphenyl)propane, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account